Vladimir L. Katanaev
Rue Michel Servet 1
Geneve, GE 1211, Switzerland
Geneve, GE 1211, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 124 publications
MYC-driven BYSL overexpression promotes hepatocellular carcinoma by suppressing nucleolar stress and inactivating the RPL5/RPL11-MDM2-p53 pathway.
Journal: Cellular signalling
Published: July 16, 2026
Safety and feasibility of oral zinc for patients with GNAO1-related disorders (ZINCGNAO1): an open-label, single-arm, single-centre, pilot trial in Germany.
Journal: EClinicalMedicine
Published: May 26, 2026
Gene supplementation therapy restores motor deficits in Gnao1[C215Y] mice and proves broad efficacy in C. elegans model.
Journal: Acta neuropathologica communications
Published: May 06, 2026
From Self-Assembly to Survival: Neuropeptide Precursor Biology in Neuroprotection.
Journal: Current neuropharmacology
Published: January 23, 2026
Small-molecule inhibitor of Gαo for GNAO1 encephalopathy.
Journal: Bioscience reports
Published: December 23, 2025
Loss of the conserved switch III region in a G protein leads to severe pediatric encephalopathy.
Journal: Science signaling
Published: October 28, 2025
Atypical GNAO1 variants in severe childhood speech disorders: clinical, genetic, and molecular insights.
Journal: Molecular autism
Published: October 07, 2025
The role of acyl cycling in endogenous G protein localization.
Journal: The Journal of biological chemistry
Published: September 17, 2025
Beyond Antioxidants: How Redox Pathways Shape Cellular Signaling and Disease Outcomes.
Journal: Antioxidants (Basel, Switzerland)
Published: August 14, 2025
Therapeutic targeting of FZD receptor proteins with biologics in cancer.
Journal: Drug discovery today
Published: July 15, 2025
Roadmap for light interaction with biophotonic surfaces and their diverse applications.
Journal: Journal of biomedical optics
Published: June 22, 2025
Last Updated: 09/26/2026